Hyderabad-based Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration to manufacture and market Escitalopram Oxalate tablets, indicated for treatment of depression associated with mood disorders.
Aurobindo gets USFDA nod for anti-depressant drug
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 13 2012 | 12:34 AM IST
